5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a
tryptaminederivative that is a
psychedelic drug. It was first made in 1958 by Edwin H. P. Young.[1] In animal experiments it was found to be in between
DMT and
5-MeO-DMT in potency[2][3] which would suggest an active dosage for humans in the 20–60 mg range. Human psychoactivity for this compound has been claimed in reports on websites such as
Erowid but has not been independently confirmed.
Legal Status
United States
5,N,N-TMT is not scheduled at the federal level in the
United States,[4][5] but it could be considered an analog of
5-MeO-DMT, in which case, sales or possession intended for human consumption could be prosecuted under the
Federal Analog Act.
^Young EH (1958). "704. The synthesis of 5-hydroxytryptamine (serotonin) and related tryptamines". Journal of the Chemical Society (Resumed): 3493–6.
doi:
10.1039/JR9580003493.